Advertisement

Topics

Enigma Diagnostics Ltd Company Profile

23:41 EDT 21st September 2018 | BioPortfolio

Enigma Diagnostics is a global leader in Point-of-Care infectious disease testing. Leveraging its extensive range of proprietary technologies and Intellectual Property, the Company has developed the Enigma® Mini Laboratory (ML) system, combining the speed and sensitivity of real-time PCR (polymerase chain reaction) with the simplicity needed for both laboratory and decentralised Point-of-Care testing.


News Articles [326 Associated News Articles listed on BioPortfolio]

Forgotten heroes of the Enigma story

Enigma Biomedical Group and Yale Sign Memorandum of Understanding to License Novel Investigational Synaptic Density Imaging Biomarker Technology

Enigma Biomedical Group (EBG) today announced execution of a Memorandum of Understanding to license Yale’s Synaptic Density Imaging (SDI) biomarker technology platform. With thi...

Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group

Emosis, 5─Diagnostics ink exclusive distribution deal for Emo─test, HIT Confirm, in CE Mark─regulated countries

Emosis, a medical device company specialising in cytomolecular diagnostics of hemostasis disorders, and 5─Diagnostics (5─D), a worldwide distributor for haemostasis products and in─vitro diagnos...

Medical News Today: A waking nightmare: The enigma of sleep paralysis

In sleep paralysis, your mind wakes up, but your body does not. You may also experience frightening hallucinations. What is this, and how can we cope?

Enigma Biomedical and Invicro Sign a Memorandum of Understanding to Co-Develop Synaptic Density Biomarker Imaging

Enigma Biomedical Group (EBG) today announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research...

2018 Thermo Fisher: Market Shares and Competitive Position by Product and CountryPerformance, Capabilities, Goals and Strategies in the Global Diagnostics Industry [Report Updated: 01011970] Prices from USD $4250

This unique market intelligence report from VPGMarketResearch provides information not available from any other published source. The report includes diagnostics sales and market share estimates by pr...

Researcher at the Center of an Epic Fraud Remains an Enigma to Those Who Exposed Him

(Science) – Sato’s fraud was one of the biggest in scientific history. The impact of his fabricated reports—many of them on how to reduce the risk of bone fractures—rippled far and wid...

Drugs and Medications [20 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [226 Associated PubMed Articles listed on BioPortfolio]

The Modern Rehabilitation Medicine Enigma: Treating People with Disabilities, but Sometimes without a Clear Diagnosis.

The process of a comprehensive rehabilitation of the disabled person may be more complicated when the diagnosis becomes vague and uncertain. Unknown data about the patient's past, mental, physical or ...

Dizziness and vertigo associated with vestibular neuronitis: the approaches to the diagnostics and treatment.

This article is focused on the peculiar features of diagnostics and treatment of dizziness and vertigo in the patients presenting with vestibular neuronitis. The authors present the detailed overview ...

Statistical primer: checking model assumptions with regression diagnostics.

Regression modelling is an important statistical tool frequently utilized by cardiothoracic surgeons. However, these models-including linear, logistic and Cox proportional hazards regression-rely on c...

Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium.

The profile of cortical neuroanatomical abnormalities in schizophrenia is not fully understood, despite hundreds of published structural brain imaging studies. This study presents the first meta-analy...

The enigma of demonetization and the unexplored consequences.

Clinical Trials [217 Associated Clinical Trials listed on BioPortfolio]

The ENIGMA Study: Eastern Inflammatory Bowel Disease Gut Microbiota

The incidence of inflammatory bowel diseases, (IBD) including Crohn's disease (CD) and ulcerative colitis (UC), is increasing in the developing world. Our recent Asia-Pacific population-ba...

Differential Diagnostics of Etiology of Acute Infections

Method for diagnostics of the origin of infections (bacterial vs viral) based on the identification of activation markers of blood neutrophils and monocytes will be developed.

Diagnostics and Pharmacotherapy for Severe Forms of TB (DMID 15-0100)

Major Research Aim: To study novel molecular diagnostics and the pharmacokinetic variability among a spectrum of TB disease states, including severe forms of TB like disseminated TB, TB me...

Bedside vs. Standard Microbiological Blood Culture Diagnostics - BEMIDIA Study

With a completely bedside blood culture diagnostics system (BACTEC blood culture system in combination with the Accelerate ID/AST System) it is possible to optimize the initial antimicrobi...

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

The purpose of this study is to assess the performance of the HTLV Blot 2.4 from patients with the following conditions: infected with HTLV and neurological conditions with symptoms simila...

Companies [932 Associated Companies listed on BioPortfolio]

Enigma Diagnostics Ltd

Enigma Diagnostics is a global leader in Point-of-Care infectious disease testing. Leveraging its extensive range of proprietary technologies and Intellectual Property, the Compan...

Enigma Inc.

Enigma is the only software company delivering a product suite that improves the efficiency, consistency and profitability of maintenance, repair and overhaul (MRO) operations and...

Enigma Diagnostics Limited

Enigma Biomedical Group

Toronto based Enigma Biomedical Group (EBG) enhances access to key technologies with a focus on molecular imaging and medicine. EBG offers a suite of services to the pharmaceutica...

Cerveau Technologies Inc.

Cerveau Technologies, Inc. is a partnership between Enigma Biomedical Group, Inc. and Sinotau Pharmaceutical Group. Cerveau's vision is to globally develop diagnostics and technol...

More Information about "Enigma Diagnostics Ltd" on BioPortfolio

We have published hundreds of Enigma Diagnostics Ltd news stories on BioPortfolio along with dozens of Enigma Diagnostics Ltd Clinical Trials and PubMed Articles about Enigma Diagnostics Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Enigma Diagnostics Ltd Companies in our database. You can also find out about relevant Enigma Diagnostics Ltd Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Infectious-diseases
Antiretroviral Therapy Clostridium Difficile Ebola HIV & AIDS Infectious Diseases Influenza Malaria Measles Sepsis Swine Flu Tropical Medicine Tuberculosis Infectious diseases are caused by pathogenic...


Corporate Database Quicklinks



Searches Linking to this Company Record